Our study reveals the potential of ITGAV as a diagnostic and prognostic biomarker, while also demonstrating its key regulatory role in immunotherapy and tumor metastasis, providing a promising novel target for digestive system cancers treatment options. Here, ITGAV is linked to digestive system cancer.